# Data-driven predictive modeling for massive intraoperative blood loss during living donor liver transplantation: Integrating machine learning techniques

**Authors:** Taiichi Wakiya, Yukihiro Sanada, Noriki Okada, Yuta Hirata, Toshio Horiuchi, Takahiko Omameuda, Yasuharu Onishi, Yasunaru Sakuma, Hironori Yamaguchi, Yoshihiro Sasaki, Naohiro Sata

PMC · DOI: 10.1371/journal.pone.0326000 · PLOS One · 2026-02-06

## TL;DR

This study uses machine learning to predict severe bleeding during liver transplants, improving risk assessment for better patient outcomes.

## Contribution

A data-driven machine learning model is developed to predict massive intraoperative blood loss in living donor liver transplants.

## Key findings

- A machine learning model achieved an AUC of 0.844 in predicting massive intraoperative bleeding.
- An online risk calculator was developed and made publicly available for clinical use.
- The model outperformed traditional logistic regression in capturing complex risk interactions.

## Abstract

Massive intraoperative bleeding (IBL) in liver transplantation (LT) poses serious risks and strains healthcare resources necessitating better predictive models for risk stratification. As traditional models often fail to capture the complex, non-linear patterns underlying bleeding risk, this study aimed to develop data-driven machine learning models for predicting massive IBL during living donor LT (LDLT) using preoperative factors.

Two hundred ninety consecutive LDLT cases from a prospective database were analyzed. Logistic regression models were built using 73 preoperative demographic and laboratory variables to predict massive IBL (≥ 80 mL/kg). The dataset was randomly split (70% training, 30% testing). The model was trained and validated through three-fold cross-validation, with backward stepwise feature selection iterated 100 times across unique random splits. The final model, based on a high stability index, was evaluated using the area under the curve (AUC).

Massive IBL was observed in 141 patients (48.6%). In standard logistic regression, significant differences were found in 42 of 73 factors between groups stratified by massive IBL, however, substantial multicollinearity limited interpretability. In the feature selection across 100 iterations, the data-driven model achieved an average AUC of 0.840 in the validation and 0.738 in the test datasets. The final model, based on 11 selected features with a high stability index, achieved an AUC of 0.844. An easy-to-use online risk calculator for massive IBL was developed and is available at: https://tai1wakiya.shinyapps.io/ldlt_bleeding_ml/.

Our findings highlight the potential of machine learning in capturing complex risk factor interactions for predicting massive IBL in LDLT.

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, F10 (coagulation factor X) [NCBI Gene 2159] {aka FX, FXA}, PROC (protein C, inactivator of coagulation factors Va and VIIIa) [NCBI Gene 5624] {aka APC, PC, PROC1, THPH3, THPH4}, SERPINF2 (serpin family F member 2) [NCBI Gene 5345] {aka A2AP, AAP, ALPHA-2-PI, API, PLI, alpha2AP}, PLG (plasminogen) [NCBI Gene 5340] {aka HAE4}, SERPINC1 (serpin family C member 1) [NCBI Gene 462] {aka AT3, AT3D, ATIII, ATIII-R2, ATIII-T1, ATIII-T2}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** IBL (MESH:D016063), thrombosis (MESH:D013927), graft failure (MESH:D051437), LDLT (MESH:D017093), ascites (MESH:D001201), infection (MESH:D007239), bleeding (MESH:D006470), hypercoagulable (MESH:D019851), primary sclerosing cholangitis (MESH:D015209), coagulation (MESH:D001778), peritonitis (MESH:D010538), BA (MESH:D001656), ALF (MESH:D017114), graft (MESH:D055589), Inflammatory (MESH:D007249), extrahepatic (MESH:D001651), fungal (MESH:D009181), bleeding tendency (MESH:C536965), portal vein thrombosis (MESH:D012170)
- **Chemicals:** ammonia (MESH:D000641), Iron (MESH:D007501), LDLT (-), bilirubin (MESH:D001663), serine (MESH:D012694), D (MESH:D003903), rituximab (MESH:D000069283), bile acids (MESH:D001647)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12880697/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12880697/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12880697/full.md

---
Source: https://tomesphere.com/paper/PMC12880697